Oramed Pharmaceuticals (ORMP) Receivables (2011 - 2015)

Oramed Pharmaceuticals' Receivables history runs 5 years deep, the most recent figure standing at $33000.0 for Q2 2015.

• Quarterly Receivables changed N/A year-over-year to $33000.0 in Q2 2015, while the trailing twelve-month figure through May 2015 was $33000.0 (changed N/A YoY) and the FY2014 annual result came in at $408000.0, changed N/A from the prior year.
• Receivables was $33000.0 for Q2 2015 at Oramed Pharmaceuticals, down from $408000.0 in the prior quarter.
• Across five years, Receivables topped out at $602532.0 in Q3 2011 and bottomed at $33000.0 in Q2 2015.
• A 5-year average of $293035.2 and a median of $219004.0 in 2012 frame the typical range for Receivables.
• Annual changes were most pronounced in 2012 — Receivables tumbled 71.4% — and 2013, when it surged 621.81%.
• Oramed Pharmaceuticals' Receivables stood at $149961.0 in 2011, then grew by 17.02% to $175483.0 in 2012, then jumped by 192.06% to $512519.0 in 2013, then decreased by 20.39% to $408000.0 in 2014, then sank by 91.91% to $33000.0 in 2015.
• Business Quant data shows ORMP's Receivables at $33000.0 in Q2 2015, $408000.0 in Q3 2014, and $512519.0 in Q2 2013.